免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

临床试验

Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension

NCT:NCT03617458 · COMPLETED

NCT编号NCT03617458
状态COMPLETED
开始日期2018-08-23
完成时间2025-08-19
SponsorVanderbilt University Medical Center (OTHER)
First posted
Last updated

简要摘要

The primary objective of this study is to determine the impact of two interventions against insulin resistance on the composite endpoint of 10% improvement in baseline six minute walk distance or improvement in World Health Organization (WHO) functional class in humans with pulmonary artery hypertension (PAH).

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。

↑